002901 Double Medical Technology Inc.
- 31.11
- +0.22+0.71%
Double Medical Technology Inc. News
Dabo Healthcare (002901.SZ): Net profit of 61,728,900 yuan in the first quarter increased 6.05% year-on-year
On April 29, Ge Longhui (002901.SZ) released its report for the first quarter of 2024, with operating income of 427 million yuan, up 9.17% year on year; net profit attributable to shareholders of listed companies was 61.7289 million yuan, up 6.05% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 49.363 million yuan, up 4.48% year on year; basic earnings per share were 0.15 yuan.
League of Nations Securities: The impact of collection is gradually clear, and the localization rate of the orthopedic industry continues to rise
Orthopedics is expected to usher in restorative growth
Dabo Healthcare (002901.SZ): 2023 net profit of 589.725 million yuan, a year-on-year decrease of 36.28%
Gelonghui, March 29丨Dabo Healthcare (002901.SZ) released its 2023 annual report. In 2023, the company achieved operating income of 1,533 billion yuan, an increase of 6.90%; net profit attributable to shareholders of listed companies was 589.725 million yuan, a year-on-year decrease of 36.28%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 10.551 million yuan, a year-on-year decrease of 88.45%; basic earnings per share were 0.14 yuan
Dabo Medical (002901.SZ): Currently, there is no application of medical information+AI medicine in product development
Gelonghui March 20 丨 An investor asked Dabo Healthcare (002901.SZ) on the investor interactive platform, “The company is a leading orthopedic enterprise. Does the company currently have any product development aspects, apply medical information+AI medicine?” The company replied that the company currently does not apply medical information+AI medicine in product development.
Is Double Medical Technology (SZSE:002901) Using Debt Sensibly?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' When we think about how
What You Can Learn From Double Medical Technology Inc.'s (SZSE:002901) P/SAfter Its 30% Share Price Crash
Double Medical Technology Inc. (SZSE:002901) shareholders that were waiting for something to happen have been dealt a blow with a 30% share price drop in the last month. The drop over the last 30 d
Recent 3.8% Pullback Would Hurt Double Medical Technology Inc. (SZSE:002901) Insiders
Key Insights Insiders appear to have a vested interest in Double Medical Technology's growth, as seen by their sizeable ownership Zhi Xiong Lin owns 84% of the company Past performance of a compa
Dabo International, the majority shareholder of Dabo Medical (002901.SZ), reduced its holdings by a total of 2.21%, and the stock reduction period expired
Dabo Healthcare (002901.SZ) issued an announcement. As of the disclosure date of this announcement, Dabo International's current holdings reduction plan is for...
Investors Still Waiting For A Pull Back In Double Medical Technology Inc. (SZSE:002901)
Double Medical Technology Inc.'s (SZSE:002901) price-to-sales (or "P/S") ratio of 11.7x might make it look like a strong sell right now compared to the Medical Equipment industry in China, where aroun
Guojin Securities: Announcement of the results of the fourth batch of consumables proposed for domestic procurement, optimistic about the continued release of artificial crystal products
It is expected that the products of domestic listed artificial crystals will continue to be released, and domestic replacement of bifocal artificial crystals will begin.
Is Double Medical Technology (SZSE:002901) Weighed On By Its Debt Load?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' So it seems the smart m
Guotai Junan: Moderate election rules and national adoption are expected to accelerate the number of domestic companies admitted to hospital
Guotai Junan released a research report saying that the localization rate of sports medicine has increased dramatically, and Guotai Junan is expected to accelerate the number of domestic companies admitted to hospital.
Dabo Healthcare (002901.SZ): Net profit for the third quarter was 4.180,600 yuan, down 87.10% year-on-year
GLONGHUI, Oct. 26 | Dabo Healthcare (002901.SZ) announced its report for the third quarter of 2023. Revenue for the reporting period was 376 million yuan, down 7.63% year on year; net profit attributable to shareholders of listed companies was 4.180,600 yuan, down 87.10% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was -116.753 million yuan; basic earnings per share were 0.0101 yuan.
Double Medical Technology's (SZSE:002901 Three-year Decrease in Earnings Delivers Investors With a 62% Loss
If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. Long term Double Medical Technology Inc. (SZSE:002901) shareholders know that all to
[Instant Analysis of BT Financial Report] Dabo Medical's 2023 Interim Report: Net asset growth is steady, gross profit margin and net interest rate are under pressure, goodwill is stable, and the balance ratio has risen
Dabo Medical Technology Co., Ltd. (stock code: 002901) is a company focusing on the production, development and sales of high-value medical consumables. The company's main products are widely used in fracture repair, spinal disease treatment, joint replacement, sports medicine and dental implants. In the 2023 semi-annual report, there have been some changes in the company's financial position. First, as can be seen from the balance sheet, Dabo Medical's total assets at the end of the period were 4.315 billion yuan, up from 3,938 billion yuan at the beginning of the period. The total debt increased from 831 million yuan at the beginning of the period to 1,121 million yuan at the end of the term
Anxin Securities: Orthopedics has gone beyond the policy bottom to focus on high-quality domestic leaders in key segmented tracks
Anxin Securities released a research report saying that orthopedics has left the bottom of the policy, and the probability that the policy will be further tightened or prices will drop further is low.
Anxin Securities: At the bottom of the orthopedic collection policy, it is now recommended to focus on Weigao Orthopedics (688161.SH), etc.
Anxin Securities believes that orthopedics has reached the bottom of the policy, that there is a low probability that the policy will be further tightened or that prices will drop further in the future, and prices have basically stabilized.
Recent 7.7% Pullback Would Hurt Double Medical Technology Inc. (SZSE:002901) Insiders
Key Insights Double Medical Technology's significant insider ownership suggests inherent interests in company's expansion 86% of the company is held by a single shareholder (Zhi Xiong Lin) Ownersh
Anxin Securities: Trauma collection renewal rules focus more gently on valuation repair opportunities for leading targets
It is recommended to focus on investment opportunities brought about by increased performance growth expectations and valuation repairs, which are the main targets of the orthopedic circuit.
Dabo Medical (002901.SZ) shareholder Dabo International and its co-actor Zhao Shaomei reduced their holdings by a total of 9.88 million shares, accounting for 2.39% of the total share capital
Dabo Medical (002901.SZ) issued an announcement. The company recently received the shareholder Dabo Medical International Investment Co., Ltd...
Analysis
Price Target
No Data
